Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain.

Journal of neurochemistry | 2018

Synaptic dysfunction and loss are core pathological features in Alzheimer disease (AD). In the vicinity of amyloid-β plaques in animal models, synaptic toxicity occurs and is associated with chronic activation of the phosphatase calcineurin (CN). Indeed, pharmacological inhibition of CN blocks amyloid-β synaptotoxicity. We therefore hypothesized that CN-mediated transcriptional changes may contribute to AD neuropathology and tested this by examining the impact of CN over-expression on neuronal gene expression in vivo. We found dramatic transcriptional down-regulation, especially of synaptic mRNAs, in neurons chronically exposed to CN activation. Importantly, the transcriptional profile parallels the changes in human AD tissue. Bioinformatics analyses suggest that both nuclear factor of activated T cells and numerous microRNAs may all be impacted by CN, and parallel findings are observed in AD. These data and analyses support the hypothesis that at least part of the synaptic failure characterizing AD may result from aberrant CN activation leading to down-regulation of synaptic genes, potentially via activation of specific transcription factors and expression of repressive microRNAs.

Pubmed ID: 29806693 RIS Download

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: K99 AG047336
  • Agency: NIA NIH HHS, United States
    Id: P30 AG062421
  • Agency: NIA NIH HHS, United States
    Id: R01 AG008487
  • Agency: NIA NIH HHS, United States
    Id: P50 AG005134
  • Agency: NIA NIH HHS, United States
    Id: 1K99AG047336-01A1
  • Agency: NIA NIH HHS, United States
    Id: R01 AG041507
  • Agency: NIH HHS, United States
    Id: AGR01AG041507
  • Agency: NIA NIH HHS, United States
    Id: R00 AG047336

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-GFP antibody (antibody)

RRID:AB_305564

This polyclonal targets GFP

View all literature mentions

Anti-HA.11 Epitope Tag (antibody)

RRID:AB_2565335

This monoclonal targets HA.11

View all literature mentions

Gene Set Enrichment Analysis (software resource)

RRID:SCR_003199

Software package for interpreting gene expression data. Used for interpretation of a large-scale experiment by identifying pathways and processes.

View all literature mentions

LIMMA (software resource)

RRID:SCR_010943

Software package for the analysis of gene expression microarray data, especially the use of linear models for analyzing designed experiments and the assessment of differential expression.

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

LIMMA (software resource)

RRID:SCR_010943

Software package for the analysis of gene expression microarray data, especially the use of linear models for analyzing designed experiments and the assessment of differential expression.

View all literature mentions

Gene Set Enrichment Analysis (software resource)

RRID:SCR_003199

Software package for interpreting gene expression data. Used for interpretation of a large-scale experiment by identifying pathways and processes.

View all literature mentions